Skip to: Content
Skip to: Site Navigation
Skip to: Search

September 6, 2008 11:06:56 AM CDT


Stories related to: progestin

Stories

2 Stories

  • March 2008
    • Women at Risk After Hormone Therapy: Study

      Women at Risk After Hormone Therapy: Study

      (Newser) - Breast cancer remains a risk for women even after they stop taking hormone therapy, researchers said yesterday. A follow-up to a 2002 study showed that women who dropped estrogen and progestin still had a 24% greater breast cancer risk. But their chance of a stroke, heart attack, or blood clot fell to normal levels after halting the therapy, Reuters reports. More »

      Tags

      breast cancer   heart attack   women's health   health study   stroke   estrogen   mammogram   Wyeth   hormone replacement therapy   blood clots   health risks   progestin

  • January 2008
    • Hormone Therapy May Triple Risk of Breast Cancer

      Hormone Therapy May Triple Risk of Breast Cancer

      (Newser) - Millions of women who take combination hormones to counter symptoms of menopause may be three times more likely to develop a certain type of breast cancer, according to a new study. Most researchers assumed it takes five years of daily estrogen and progestin to increase cancer risks, but the threat may increase substantially in just three years, according to research published in Cancer Epidemiology, Biomarkers and Prevention. More »

      Tags

      breast cancer   estrogen   mammogram   menopause   progestin

2 Stories

Today's Most Popular

Premium Articles from HighBeam

Find more articles like this

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »